Key result
VLDL-r localizes to plaque-associated microglia and neurons, with splice variant ratios unchanged in Alzheimer disease.
Observational
Answers are grounded in this paper and cite their sources.
The very low density lipoprotein receptor (VLDL-r) is a cell-surface molecule specialized for the internalization of multiple diverse ligands, including apolipoprotein E (apoE)-containing lipoprotein particles, via clathrin-coated pits. Its structure is similar to the low-density lipoprotein receptor (LDL-r), although the two have substantially different systemic distributions and regulatory pathways. The present work examines the distribution of VLDL-r in the central nervous system (CNS) and in relation to senile plaques in Alzheimer disease (AD). VLDL-r is present on resting and activated microglia, particularly those associated with senile plaques (SPs). VLDL-r immunoreactivity is also found in cortical neurons. Two exons of VLDL-r mRNA are differentially spliced in the mature receptor mRNA. One set of splice forms gives rise to receptors containing (or lacking) an extracellular O-linked glycosylation domain near the transmembrane portion of the molecule. The other set of splice forms appears to be brain-specific, and is responsible for the presence or absence of one of the cysteine-rich repeat regions in the binding region of the molecule. Ratios of the receptor variants generated from these splice forms do not differ substantially across different cortical areas or in AD. We hypothesize that VLDL-r might contribute to metabolism of apoE and apoE/A beta complexes in the brain. Further characterizations of apoE receptors in Alzheimer brain may help lay the groundwork for understanding the role of apoE in the CNS and in the pathophysiology of AD.
No takes yet. Share an insight, caveat, or question.
Christie et al. (1996) conducted an observational in Alzheimer's Disease. Very low-density lipoprotein receptor (VLDL-r) expression vs. Non-Alzheimer's disease cortical areas was evaluated on Distribution of VLDL-r and ratios of receptor splice variants in the central nervous system and in relation to senile plaques in Alzheimer's disease. Very low-density lipoprotein receptor (VLDL-r) is expressed on plaque-associated microglia and cortical neurons, with receptor splice variant ratios from 2 exons showing no substantial difference in AD.
Synapse has enriched 10 related papers. Consider them for comparative context: